Sonia Maria Poli

Title: Sonia Maria Poli: Innovator in Pharmaceutical Modulation

Introduction

Sonia Maria Poli is a distinguished inventor based in Geneva, Switzerland. She has made significant contributions to the field of pharmaceutical sciences, particularly in the development of compounds that modulate the mGlu5 receptor. Her work is pivotal in addressing central nervous system disorders and other related conditions.

Latest Patents

Sonia Maria Poli holds a patent for the invention titled "Mono-phosphate salt of 6-fluoro-2-[4-(pyridin-2-yl)but-3-yn-1-yl]imidazo[1,2A]pyridine (dipraglurant) and polymorphs thereof as negative allosteric modulator of MGLU5 receptor." This invention relates to both crystalline and amorphous forms of the compound, which are useful in the treatment and prevention of various disorders modulated by mGlu receptors. The patent outlines methods for creating these solid forms and emphasizes their potential in pharmaceutical compositions.

Career Highlights

Throughout her career, Sonia has worked with notable companies in the pharmaceutical industry, including Addex Pharma and F. Hoffmann-La Roche AG. Her experience in these organizations has allowed her to refine her expertise in drug development and innovation.

Collaborations

Sonia has collaborated with esteemed colleagues such as Béatrice Bonnet and Torsten Hoffmann. These partnerships have contributed to her success and the advancement of her research.

Conclusion

Sonia Maria Poli is a remarkable inventor whose work in pharmaceutical modulation has the potential to significantly impact the treatment of central nervous system disorders. Her innovative approaches and collaborations continue to drive advancements in the field.